Revvity Inc.
USUSDRevvity Inc. (US:RVTY) — Biotechnology: Laboratory Analytical Instruments. Nombre de places boursières sur lesquelles les actions de la société sont cotées : 3. Sur cette page : cours et graphique, dividendes, principaux actionnaires et historique du nombre d'actions.
À propos de l'entreprise
- Site web
- revvity.com
- Secteur
- Industrials · Biotechnology: Laboratory Analytical Instruments
- Siège social
- Waltham, United States
- PDG
- Prahlad R. Singh
- Employés
- 11 000
- Actions en circulation
- 111.59 M au 2026-08-06
- Flottant
- 102.49 M
- Capitalisation boursière
- 16.63 Md USD
- Initiés
- 0.26%
- Investisseurs institutionnels
- 96.55%
- Secteur d'activité (SIC)
- Laboratory Analytical Instruments
- LEI
- 549300IKL1SDPFI7N655
- Taux de distribution
- 13.4%
- FCF
- 558 M USD6%
- Dette
- 3.21 Md USD3.9 ans de FCF
- Ancienneté du dividende
- 43 ans
- Bénéfices, FCF et dividendes versés — pour les 12 mois précédant 05.07.2026 (le dernier rapport de l'entreprise).
Description
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. The company also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray , EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Dividendes
Revvity Inc. (RVTY) verse des dividendes trimestriels. Au cours des 12 derniers mois, 0.28 USD par action ont été versés (versements : 4). Cela représente environ 0.18% du cours actuel de l'action. La prochaine date ex-dividende est le 23.10.2026 : 0.07 USD par action, versement le 13.11.2026. Historique des dividendes ininterrompu : 43 ans.
| Date ex | Versement | Montant | % | Type | Ticker |
|---|---|---|---|---|---|
| 2026-10-23 annoncé | 2026-11-13 | 0.0700 USD | 0.0/0.2 % | trimestriel | US:RVTY |
| 2026-07-17 | 2026-08-07 | 0.0700 USD | 0.0/0.2 % | trimestriel | US:RVTY |
| 2026-04-17 | 2026-05-08 | 0.0700 USD | 0.0/0.2 % | trimestriel | US:RVTY |
| 2026-01-16 | 2026-02-06 | 0.0700 USD | 0.0/0.2 % | trimestriel | US:RVTY |
| 2025-10-17 | 2025-11-07 | 0.0700 USD | 0.0/0.2 % | trimestriel | US:RVTY |
| 2025-07-18 | 2025-08-08 | 0.0700 USD | 0.0/≈0.2 % | trimestriel | US:RVTY |
| 2025-04-17 | 2025-05-09 | 0.0700 USD | 0.0/≈0.2 % | trimestriel | US:RVTY |
| 2025-01-17 | 2025-02-07 | 0.0700 USD | 0.0/≈0.2 % | trimestriel | US:RVTY |
Actualités de cette semaine
Communiqués de presse du site de l'entreprise pour les investisseurs, mis à jour chaque jour. Les liens mènent au site de l'entreprise. Les titres sont dans la langue originale, comme sur le site web de l'entreprise.
| 06.10.2026 | Revvity to Host Investor Day |
Principaux actionnaires
| Détenteur | Participation | Actions | Date du rapport |
|---|---|---|---|
| T. Rowe Price Investment… | 16.37% | 18.26 M | 2026-06-30 |
| T. ROWE PRICE CAPITAL AP… | 10.2% | 11.38 M | 2026-06-30 |
| Jupiter Topco LLC | 7.74% | 8.64 M | 2026-06-30 |
| Edgepoint Investment Gro… | 7.66% | 8.54 M | 2026-06-30 |
| Blackrock Inc. | 6.86% | 7.66 M | 2026-06-30 |
| Vanguard Capital Managem… | 6.54% | 7.3 M | 2026-06-30 |
| JANUS INVESTMENT FUND-Ja… | 5.15% | 5.75 M | 2026-06-30 |
| Price (T.Rowe) Associate… | 4.96% | 5.53 M | 2026-06-30 |
| Vanguard Portfolio Manag… | 4.28% | 4.77 M | 2026-06-30 |
| State Street Corporation | 3.89% | 4.34 M | 2026-06-30 |
| Victory Capital Manageme… | 3.27% | 3.65 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.18% | 3.55 M | 2026-06-30 |
| Dimensional Fund Advisor… | 3.07% | 3.43 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.59% | 2.89 M | 2026-06-30 |
| -Price (T.Rowe) U.S. Val… | 2.41% | 2.69 M | 2026-06-30 |
| TR PRICE-Price (T.Rowe)… | 2.41% | 2.69 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.29% | 2.56 M | 2026-06-30 |
| JNL Series Trust-JNL/T.… | 2.27% | 2.53 M | 2026-06-30 |
| Victory Portfolios-Victo… | 2.12% | 2.37 M | 2026-06-30 |
| T. Rowe Price Value Fund… | 1.93% | 2.16 M | 2026-06-30 |
| Invesco Exchange-Traded… | 1.67% | 1.87 M | 2026-08-31 |
| SINGH PRAHLAD R (Chief E… | ≈0.09% | 105 676 | 2026-08-13 |
| GOLDBERG JOEL S (General… | ≈0.09% | 105 223 | 2026-08-14 |
| BARRETT PETER (Director) | ≈0.03% | 28 293 | 2026-05-07 |
| WITNEY FRANKLIN R. PH.D.… | ≈0.02% | 23 354 | 2026-05-07 |
| CHAPIN SAMUEL R. (Direct… | ≈0.02% | 22 676 | 2026-05-07 |
| VICTOR MIRIAME (Officer) | ≈0.02% | 18 122 | 2026-02-24 |
| WITZ PASCALE (Director) | ≈0.01% | 15 985 | 2026-05-07 |
| KRAKOWIAK MAXWELL (Chief… | ≈0.01% | 14 781 | 2026-09-21 |
| MICHAS ALEXANDROS P (Dir… | — | — | 2026-08-25 |
| MICHAS ALEXIS P (Directo… | — | — | 2025-08-27 |
